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Insub-SaharanAfrica,approximately30millionpregnantwomenareatriskofcontractingmalariaannually.Nearly36%ofhealthy
pregnant women receiving routine antenatal care tested positive for Plasmodium falciparum HRP-II antigen in Ghana. We tested
the hypothesis that asymptomatic HRP II positive pregnant women expressed a unique Th1 and Th2 phenotype that diﬀers from
healthy controls. Plasma from healthy (n = 15) and asymptomatic (n = 25) pregnant women were evaluated for 27 biomarkers
(IL-1b, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, IL- 17, Eotaxin, bFGF-2, G-CSF, GM-CSF, IFN-γ,
IP-10, MCP-1, MIP-1α, MIP-1β, PDGF-bb, RANTES, TNF, and VEGF) associated with Th1 and Th2 cytokine homeostasis. IL-10
and G-CSF levels were elevated in the asymptomatic group when compared with the healthy group (P = .031 and .041, resp.). The
median ratios of IL-1β:5, IL-1β:10, IL-1β:G-CSF, IL-1β:Eotaxin, IL-12:G-CSF, IL-15:10, IL-17:G-CSF, IL-17:Eotaxin, TNF:IL-4,
TNF:IL-5, and TNF:G-CSF were signiﬁcantly diﬀerent among the two groups. Thus, asymptomatic malaria carriage may be linked
to circulating levels of IL-10 and G-CSF.
1.Introduction
The World Health Organization estimates that around 250
millioncasesofmalariainfectionsand1–3millionassociated
deaths globally are reported annually [1]. Infection with
Plasmodium falciparum has a wide spectrum of manifes-
tations that are classiﬁed into three main clinical groups:
asymptomatic (presence of malaria parasite without malaria
symptoms), mild, and severe malaria. In malaria-endemic
areas, a signiﬁcant proportion of individuals considered
asymptomatic, harbor parasites without presenting signs of
clinical malaria [2]. The signiﬁcance of such asymptomatic
infections in the broader context of malaria transmission
has been evaluated in diverse situations using complemen-
tary approaches [3–6]. Variant-speciﬁc immunity has been
used to explain the low-grade infection during extended
periods without clinical symptoms [7]. Studies suggest
that long-term asymptomatic carriage may represent a
form of tolerance to parasites in individuals such that
asymptomatic carriage may protect these individuals from
developing severe malaria [3–5]. Older individuals are more
likely to develop uncomplicated malaria or asymptomatic
parasitemia [8]. In high malaria endemic areas, protection
from severe malaria is acquired early during childhood,
although it takes longer to be protected from less severe
disease [9]. Although immunoprotective mechanisms clear
a large proportion of infected erythrocytes, a subset persists
in the circulation leading to asymptomatic parasitemia
[4, 9].
Conversely,asymptomaticcarriagemayrepresentamode
of entry to symptomatic malaria, especially in young chil-
dren [6, 10]. Many asymptomatic infections go undetected2 Infectious Diseases in Obstetrics and Gynecology
and untreated while causing little or no clinical mani-
festation. The extent of the prevalence of asymptomatic
parasitemia in a given population is inversely related to
the population’s susceptibility to clinical disease [11, 12],
but more importantly, asymptomatic individuals are major
reservoirs of infection [13, 14]. Gouagna et al. [15]h a v e
demonstrated that parasites from asymptomatic individuals
are more infectious to mosquitoes than are parasites from
symptomatic individuals. These results have driven current
presumptive intermittent antimalarial treatment strategy
for asymptomatic individuals, regardless of their malaria
infection status, to reduce malaria morbidity and mortality
[16]. Furthermore, ﬁeld surveys of malaria using microscopy
have often failed to detect very low-level parasitemia, which
is common among asymptomatic patients.
During successful pregnancies, maternal leukocytes pro-
duce predominately Th2-type cytokines to prevent initiation
of inﬂammatory and cytolytic-responses that might damage
the integrity of the placental barrier [17]. In response to
invading pathogens, Th1-type cytokines may be produced
that reverses the Th2-type bias [18]. The deviation in
local and systemic immune response towards a Th2 bias
may leave pregnant woman more open to Th1-dependent
infections such as malaria thereby contributing in increased
morbidity. A previous study in Ghana observed 36.3%
of asymptomatic P. falciparum infection among pregnant
women [19]. Similarly, Gabon and Cameroon have reported
57% and 82.4% asymptomatic infection prevalence respec-
tively [20, 21] suggesting that pregnant women may present
cytokine or chemokine levels that may confer less suscep-
tibility to symptomatic malaria thereby harboring malaria
parasite without showing any symptoms. The current study
examined the immune modulators associated with asymp-
tomatic parasitemia in pregnant women and compared with
health-uninfected controls. The levels of malaria-associated
cytokine, chemokine, and growth factors in asymptomatic
healthy pregnant women were evaluated simultaneously to
characterize and identify potential biological factors induced
by asymptomatic P. falciparum infections that provide
insights into malaria immunopathogenesis as well as targets
for adjunctive therapies to prevent malaria morbidity and
mortalities.
2. Methods
2.1.StudySubjectsandSamples. Womenwhohadasingleton
and uncomplicated pregnancy with no clinical symptoms
of malaria presenting at their third trimester for delivery at
two hospitals in Kumasi Ghana, the Komfo Anokye Teaching
Hospital and the Manhyia Polyclinic in Kumasi, November
to December 2006 were enrolled after informed consent.
Medical history before and during pregnancy was obtained
and recorded. 746 women with ages ranging from 15 to
48 were enrolled with an average age of 26.8 years. Venous
blood samples were collected after enrollment. Red blood
cells and plasma were separated and stored at −80
◦C until
ready to use. Hemoglobin levels, malaria antigens in the
blood as well as presence of helminthes in stool samples were
determined. Malaria antigen levels were determined by using
a Malaria Antigen ELISA kit (CELISA, Cellabs, Australia).
This kit measures HRP II production during growth and
multiplication [22]o fP. falciparum at a speciﬁcity of 96%
and sensitivity of 98% in whole blood or plasma and
can detect P. falciparum parasites at a limit of detection
of 0.001% [23]. Study participants were categorized into
asymptomatic carriers (ACs) and healthy controls (HCs).
The AC group were positive for HRPII while HC were
negative for HRPII. Determination of hookworms, Ascaris
lumbricoides, Strongyloides stercoralis, and Trichuris trichura
w a sd o n ea sp r e v i o u s l yd e s c r i b e d[ 19]. Stool samples were
processed within 12 hours of collection and examined
microscopically within 1 hour of preparation to avoid
missing hookworm ova [19].
2.2. Multiplexed Microsphere Cytokine Immunoassay. Forty
plasma samples were randomly selected from 746 sam-
ples from pregnant women (15 healthy control and 25
asymptomatic carriers) and were evaluated simultaneously
for circulating levels of 17 cytokines (IL-1β,I L - 1 r a ,I L -
2, IL-4, IL-5, IL-6, IL-7, IL-9, IL-10, IL-12, IL-13, IL-
15, IL-17, G-CSF, GM-CSF, TNF, IFN-γ), 7 chemokines
(IL-8, Eotaxin, IP-10, MCP-1, MIP-1α,M I P - 1 β, RANTES),
and 3 growth factors (bFGF-2, PDGF-bb, VEGF) using
a commercially available multiplex bead-based cytokine
assay coupled with the Luminex system (Austin, TX) and
human-speciﬁc magnetic beads Bio-Plex Cytokine Kit (Bio-
Rad, Hercules, CA). Biological factor levels were measured
using optimal concentrations of standards and antibodies
according to the manufacturer’s instructions. Brieﬂy, plasma
samples were diluted 1:4 in Bio-Plex sample diluents and
an eight point, broad range cytokine standard was prepared
by serial dilution from a cytokine stock. Fifty microliters
of diluted sample or standard were transferred to 96-
well ﬁltration plate containing anticonjugated beads. The
plate was shaken for 30 seconds at 1,100rpm, reduced to
300rpm,andincubatedfor60minutesatroomtemperature.
After incubation and washes, detection antibody (2mg/mL)
was added and incubated for 30 minutes. After 3 washes,
streptavidin-PE was added and incubated for 10 minutes.
Beads were mixed before reading on the Bio-Plex Suspension
ArraySystem.ThedatawasanalyzedusingBio-PlexManager
software with 5-parameter logistic (5PL) regression curves.
2.3. Statistical Analysis. To normalize the distribution of
cytokine values, the data was log transformed. Diﬀerences in
individual biological factor concentrations between HC and
AC groups were compared using nonparametric Kruskal-
Wallis one-way analysis of variance (ANOVA) on ranks.
Dunn’s method was used for all pairwise multiple compari-
sonprocedurestoisolatethegrouporgroupsthatdiﬀerfrom
theothers.Thediﬀerencesinproinﬂammatoryorangiostatic
to anti-inﬂammatory or angiogenic cytokine median ratios
were compared between the two groups using ANOVA to
determine the balance or disequilibrium of Thl and Th2
determinants between the groups. Box plots of median
biomarker concentrations with 25th and 75th percentilesInfectious Diseases in Obstetrics and Gynecology 3
Table 1: Description of the pregnant women in the study. HC
denotes healthy control and AC denotes asymptomatic carrier. The
values for hemoglobin was mean ± SD.
Characteristics HC AC P-value
No. of Subjects 15 25
HRP II/Malaria Negative Positive
Mean Hemoglobin Level
(g/dL)
12.63 ±1.17 10.98 ±2.32 .017
%A n e m i a( H b< 11g/dL) 13 44
Ascaris Infection 02
Hookworm Infection 01
Trichiuris Infection 01
Strongyloides Infection 00
Enterobius Infection 00
Taenia Infection 00
were plotted. Values outside the bars for 10th and 90th
percentiles were plotted as points. Statistical signiﬁcance
for each biological factor was set at a two-tailed P<. 05.
SigmaPlotsoftwareversion10(SystatSoftwareInc.,SanJose,
CA) was used to calculate statistics and plot graphs.
3. Results
3.1. Patient Characteristics. Nearly one-third (30.2%) of the
746 participants were primigravidae and 98.7% had at least
one prenatal visit prior to delivery with most occurring
in the third trimester of pregnancy [19]. However, among
the 40 random samples selected for the present study, the
participants were at least secundigravidae. The prevalence
of P. falciparum among the participants was 36% and
16.6% had malarial and helminth coinfection [19]. Out
of the 40 randomly selected samples, 13% HC and 44%
AC were anemic (hemoglobin < 11g/dL) (Table 1). The
mean hemoglobin levels were signiﬁcantly higher in the HC
(12.63±1.17) than AC (10.98±2.32), P = .017. None of the
HC had helminth infection and 16% of the AC samples had
one or multiple helminth infection. The helminth infection
did not appear to aﬀect the anemic outcome observed in the
AC group (Table 1).
3.2. Biomarker Levels in Healthy Controls and Asymptomatic
Carriers. Pairwise comparisons were used to determine the
levels of signiﬁcance of the diﬀerences between the plasma
biological factor levels of the two groups (HC and AC)
after controlling for age and primigravidae. The plasma
levels of 27 biological factors were grouped into proin-
ﬂammatory, anti-inﬂammatory, and angiogenic/angiostatic
biomarkers and analyzed. The proinﬂammatory and angio-
genic/angiostatic levels demonstrated marginal changes but
did not show statistically signiﬁcant diﬀerences between
the HC and AC groups (data not shown). Among the
anti-inﬂammatory biomarkers evaluated, IL-10 and G-CSF
were signiﬁcantly (P<. 05) elevated among the AC group
compared to HC group (Figure 1). In addition, among the
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Figure 1: Concentration of plasma IL-10 and G-CSF in pregnant
women with asymptomatic malaria (n = 25) and healthy controls
(n = 15).Boxplotsrepresentmedianlogconcentration(pg/ml)and
25th and 75th percentiles. Outliers are shown as points outside the
10th and 90th percentile bars. HC represents healthy controls. AC
denotes asymptomatic carriers. ∗P<. 05 is statistically signiﬁcant.
AC group comparing helminth infection with absence of
helminth infection, there were no signiﬁcant diﬀerences
in the peripheral biological factor levels suggesting that
helminth infection did not inﬂuence the peripheral biolog-
ical factor levels.
3.3. Biomarker Ratios in Healthy Controls and Asymptomatic
Carriers. To determine the inﬂuence of parasite antigen
on Th1and Th2 homeostasis, plasma proinﬂammatory4 Infectious Diseases in Obstetrics and Gynecology
Table 2: Comparison of selected plasma biomarker median ratios
between the HC and AC Group. Statistical comparison of median
ratios of proinﬂammatory, angiostatic versus anti-inﬂammatory
and angiogenic factors in diﬀerent subject groups. P<. 05
considered statistically signiﬁcant.
Proinﬂammatory or Angiostatic
versus Anti-inﬂammatory or
Angiogenic Biomarker Median
Ratio
AC HC Overall P
Value
IL-1β:IL-5 2.73 3.31 .021
IL-1β:IL-10 0.74 1.06 .040
IL-1β:G-CSF 0.21 0.33 .003
IL-1β:Eotaxin 0.18 0.31 .001
IL-12:G-CSF 0.261 0.420 .040
IL-15:IL-10 0.163 0.848 .039
IL-17:G-CSF 1.102 1.723 .036
IL-17:Eotaxin 1.004 1.627 .030
TNF:IL-4 15.335 24.518 .047
TNF:IL-5 9.974 15.510 .031
TNF:G-CSF 0.831 1.855 .002
(IL-1β, IL-2, IL-6, IL-8, IL-12, IL-15, IL-17, GM-CSF, IFN-
γ, MCP-1, MIP-1α,M I P - 1 β, RANTES, TNF) or angiostatic
(IP-10, IL-12) to anti-inﬂammatory (IL-1ra, IL-4, IL-5, IL-
6, IL-9, IL-10, IL-13, G-CSF, Eotaxin) or angiogenic (IL-7,
IL-8,bFGF-2,PDGF-bb,VEGF)cytokinemedianratioswere
comparedbetweenthetwogroups(HCandAC).Comparing
the median ratios of proinﬂammatory to anti-inﬂammatory
factors and angiogenic to angiostatic biomarkers among
HC and AC groups, biomarker median ratios (IL-1β:5, IL-
1β:10, IL-1β:G-CSF, IL-1β:Eotaxin, IL-12:G-CSF, IL-15:10,
IL-17:G-CSF, IL-17:Eotaxin, TNF-α:IL-4, TNF:IL-5, TNF-
α:G-CSF) were statistically diﬀerent among HC and AC
(Table 2).
4. Discussion
Asymptomatic malaria (presence of malaria parasite without
symptoms) is prevalent in highly endemic areas in Africa
[24]. It is suggested that asymptomatic parasitemia con-
fers partial immunity and protection against symptomatic
malaria [5, 25]. On the other hand, asymptomatic indi-
viduals constitute a remarkably large reservoir for malaria
transmission or could be a precursor in the progression of
symptomatic form of malaria. This study was conducted
after reviewing data generated in a previous study [19]a n d
ﬁnding a remarkably high number (36%) of asymptomatic
patients recorded as healthy controls. We acknowledge that
the cross sectional measurement of parasitemia and biolog-
ical factor levels in host blood and the lack of follow-ups
to determine the true impact of asymptomatic parasitemia
is a limitation of this study. Nevertheless, the importance of
our observation is predicated on recent studies that indicate
that individuals with asymptomatic parasitemia may have a
higher risk of developing symptomatic malaria than those
without evidence of parasitemia [26]. In our study, the AC
group had lower hemoglobin level compared to the HC
group (Table 1). This lower level of hemoglobin could be
due to the presence of chronically low parasitemia causing
extensive destruction of red blood cells. Many asymptomatic
infections are undetected by microscopy and thus most
asymptomatic individual do not receive required treatment
thereby rendering them susceptible to the risks associated
with both symptomatic and asymptomatic malaria. This
persistent problem has resulted in the proposed presumptive
intermittent treatment strategy for asymptomatic individ-
uals, regardless of their malaria infection status, to reduce
malaria morbidity and mortality [16]. This therapeutic
method mayadversely resultinacceleratingthedevelopment
ofresistanceagainstanti-malarialdrugssuggestinganurgent
need to determine the true infection status before treatment.
This approach is useful in decreasing the prevalence of
asymptomatic malaria and the negative consequence of drug
resistance to anti-malarial drugs.
The present study examined a broad range of immune
mediators, including cytokines, chemokines, and markers
of apoptosis and angiogenesis in healthy and asymptomatic
malaria carrier pregnant women. The immunological rel-
evance of these biological factors associated with asymp-
tomatic malaria have been previously established [27, 28].
Due to the lack of concurrent studies of inﬂammatory,
apoptotic, and angiogenic factors in appropriate time-
matched symptomatic patients, the results are discussed in
context. Proinﬂammatory Th1-type cytokines are thought to
be critical to the control of exoerythrocytic and erythrocytic
P. falciparum infection [29, 30], but their exaggerated pro-
duction may also contribute to organ damage, particularly
in the brain in cerebral malaria cases. It is widely accepted
that anti-inﬂammatory Th2-type cytokines downregulate
Th1-derived cytokines. Th2-type cytokines, such as IL-10,
regulate Th1-cytokines and prevent severe forms of malaria
in some animal models [31]. The regulation of TNF levels
by IL-10 appears to contribute to the prevention of severe
malarial anemia in humans [32–34]. However, the role that
IL-10 plays may depend on its levels, since very high levels
of IL-10 have been associated with severe malaria in humans
[35] and some animal models [36]. In our analysis, higher
levels of IL-10 were observed in the AC group than the HC
group. IL-10 is a key cytokine involved in both protection
and immunopathology during malaria. High levels of IL-10
may be beneﬁcial by reducing the inﬂammatory response,
but may be detrimental by decreasing antiparasitic cellular
immune responses. IL-10 is an anti-inﬂammatory cytokine
that acts in part by blocking monocyte and macrophage
production of inﬂammatory cytokines such as IL-6, TNF,
and IL-l [37]. Animal studies have suggested that IL-10
may play a regulatory role that modulates susceptibility to
parasite infection. In particular, IL-10 inhibits microbicidal
activity of IFN-γ-treated macrophages against intracellular
parasites such as Toxoplasma gondii [38], Trypanosoma
cruzi [39]a n dLeishmania major [40], and the killing of
extracellular Schistosoma mansoni schistosomulas [41]. IL-10
has been previously observed to be elevated during malarial
episodes in nonpregnant [42, 43] and pregnant women [44].Infectious Diseases in Obstetrics and Gynecology 5
Both increased and decreased levels of IL-10 have been
associated with poor malaria outcomes. Low levels of IL-
10 or low IL-10 to TNF ratios were associated with severe
malarial anemia in African children [32, 34], while high IL-
10 levels were associated with reduced ability to eliminate
malaria parasitemia in Tanzanian children [45]. Thus, the
high levels of IL-10 observed in the AC group may reduce
their ability to eliminate or clear malaria parasitemia as seen
in the HC.
Cytokines may stimulate beneﬁcial immunological
responses in falciparum malaria by inducing acute phase
responses, inhibition of parasitic growth, and clearance of
vascular parasites and debris. Neutrophils are stimulated by
cytokines such as TNF or INF-γ in order to increase parasite
destruction [46]. In the present study, it seems that G-CSF
may be involved in controlling P. falciparum parasitemia,
which ultimately results in the asymptomatic condition
observedinourACgroup.G-CSFhasbothanti-infectiveand
anti-inﬂammatory eﬀects [47]. G-CSF enhances phagocyto-
sis and increases chemotaxis and antibody-dependent cyto-
toxicity suggesting its involvement in anti-malarial defense
by activating neutrophils and acting as an immunomodu-
latory factor [47]. Surprisingly, G-CSF levels were elevated
in the AC compared to HC suggesting that this factor may
be involved in maintaining low parasitemia levels observed
in the asymptomatic individual. Functional studies on the
association of G-CSF and IL-10 with asymptomatic malaria
are much needed to reveal their contribution to the spread
and severity of malaria.
Maternal leukocytes produce predominately Th2-type
cytokines shifting the cytokine balance towards Th2-type
response during pregnancy to prevent initiation of inﬂam-
matory that might damage the integrity of the placental
barrier [17]. In response to invading pathogens,Th1-type
cytokines may be produced to reverse the Th2-type bias
[18] to aid in elimination of parasites by enhancing phago-
cytic activity of macrophages, generating reactive oxygen
intermediates, and stimulating the proliferation of T cells
[48]. However, our median ratio result indicates that there
was signiﬁcance bias towards a Th2-type proﬁle in the AC
group with low pro- to anti-inﬂammatory ratios compared
to the HC group (Table 2). This deviation in immune
response towards a Th2 bias may explain the asymptomatic
observation in the AC group due to the fact that this
group has a less robust Th1-type response to eliminate
malaria parasites compared to the HC group. In addition,
the Th2 bias may leave pregnant AC more open to Th1-
dependent infections that may result in increased morbidity
in pregnancy.
We acknowledge that this study has limitations that
can be investigated in future studies. The current study
did not include cytokine proﬁles of nonpregnant women
and pregnant women with malaria as well as asymptomatic
nonpregnant women to determine whether our observations
were unique to pregnant women. However, IL-10 has been
observed to be elevated during malarial episodes in nonpreg-
nant [42, 43] and pregnant women [44]. Although our study
lacked malaria positive pregnant women, comparing the
results to other studies in which malaria positive pregnant
women were included suggests that the levels of peripheral
IL-10 in the AC group were lower than pregnant women
with placental malaria [49]. In addition, studies in murine
models of malaria have suggested that IL-10 response during
infection may be associated with the disease exacerbation
[36].
To the best of our knowledge, there are no compre-
hensive prospective studies that describe cytokine proﬁle
during pregnancy, therefore, we do not know whether the
observation made in this study may have been inﬂuenced
by pregnancy-speciﬁc conditions. However, the increase in
asymptomatic cases [19–21, 50, 51] highlights the alarming
potential of malaria as a serious public health issue under-
scoring the need for tighter surveillance [50]. Asymptomatic
individuals not only serve as a source of maintenance of
intense malaria transmission during the peak season but
could also perpetuate resistance through the inappropriate
use of drugs [51].
In summary, cytokine, chemokine, and growth factor
evaluation in asymptomatic healthy pregnant women reveal
an association between increased plasma concentrations
of IL-10 and G-CSF. Thus, susceptibility to symptomatic
malaria in pregnancy may be associated with high levels
of IL-10 and G-CSF and dysregulation of pro and anti-
inﬂammatory factors in pregnant women. In the absence of
studies explaining the functional implication of this ﬁnding
for the asymptomatic condition observed in these pregnant
women, we propose that assessment of these biological
factors in conjunction with rapid detection of P. falciparum
HRP-II and PCR-based methods could be a useful tool for
predicting risk for asymptomatic malaria carriage.
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